– the leading provider of online annual reports to individual and institutional investors.

Ipsen Group

Ipsen Group formly known as Tercica Inc. is a biopharmaceutical company focused on the development and commercialization of rhIGF-1 for the treatment of short stature, diabetes and other endocrine system disorders.

No investor fact sheets added yet
No responsibility reports added yet

Browse Reports